Current Studies

Chronic Migraines in Adolescents

To evaluate the efficacy and safety of a single treatment cycle of Botox in adolescents with chronic migraine

Who qualifies for this study?

You may qualify for this study if:

  • You are 12 to 18 years of age
  • You have 15 or more headache days, with each day consisting of a total of 1 or more hours of headache
  • Chronic migraine for at least 6 months

Qualified participants may receive:

  • Study related physician’s care and close monitoring
  • Study related medications and exams
  • Compensation for time and travel

Chronic Migraine in Adults

The purpose of this study is to evaluate the long-term efficacy of Botox in patients with chronic migraines.

Who qualifies for this study?

You may qualify for this study if:

  • You are 18 years of age or older
  • You have been diagnosed with chronic migraine, and have 15 or more headaches per month lasting 4 hours a day or longer
  • Have NOT have Botox for any reason or indication in the past

Qualified participants may receive:

  • Study related physician’s care and close monitoring
  • Study related medication

For more information or to sign up for this study please contact us and let us know you what study you want to participate in.

ALS (Amyotrophic lateral sclerosis)

Who qualifies for this study?

You may qualify for this study if:

  • You are between the ages of 18-79
  • Have been diagnosed with Amyotrophic lateral sclerosis ( ALS)

Qualified participants may receive:

  • Compensation for time and travel

For more information or to sign up for this study please contact us and let us know you what study you want to participate in.

Multiple Sclerosis

Several studies are now underway to evaluate the effectiveness of several medications for the treatment of relapsing-remitting multiple sclerosis

Who qualifies for these studies?

You may qualify for any of these studies if:

  • You are between the ages of 18 to 65
  • You have been diagnosed with Relapsing-Remitting multiple sclerosis

Qualified participants may receive:

  • Study related physician’s care and close monitoring
  • Study related medications, exams and blood tests
  • Compensation for time and travel

Secondary Progressive MS

A clinical research study to find out if the drug BAF312 (Siponimod) is safe and has beneficial effects in people who have Secondary Progressive Multiple Sclerosis

Who qualifies for this study?

You may qualify for this study if:

  • You are between the ages of 18 to 60
  • You have prior history of relapsing-remitting MS

Qualified participants may receive:

  • Study related physician’s care and close monitoring
  • Study related medications, exams and blood tests
  • Compensation for time and travel

For more information or to sign up for this study please contact us and let us know you what study you want to participate in.

Parkinson’s disease

A clinical study to find out how well the investigational medication LCIG and the investigational delivery system work to treat non-motor symptoms in subjects with advanced Parkinson’s disease

Who qualifies for this study?

You may qualify for this study if:

  • You are at least 30 years of age
  • You have been diagnosed with idiopathic Parkinson’s disease
  • You must be able to perform the cognitive battery without assistance.

Qualified participants may receive:

  • Study related physicians care and close monitoring
  • Study related medications, exams and blood tests

For more information or to sign up for this study please contact us and let us know you what study you want to participate in.